| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/30/2009 | US20090192140 Iap bir domain binding compounds |
| 07/30/2009 | US20090192139 Calcitonin gene-related peptide (CGRP) receptor antagonists such as N-[1-(2,3-Difluorobenzyl)-5-oxo-4-(2,22-trifluoroethyl)-1,4-diazepan-6-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide, used for treating headaches |
| 07/30/2009 | US20090192138 compounds |
| 07/30/2009 | US20090192137 Dialysis method |
| 07/30/2009 | US20090192136 Benzoyl-piperazine derivatives |
| 07/30/2009 | US20090192135 Human Niemann Pick C1-Like 1 Gene (NPC1L1) Polymorphisms and Methods of Use Thereof |
| 07/30/2009 | US20090192134 Compounds |
| 07/30/2009 | US20090192133 Treatment for achondroplasia |
| 07/30/2009 | US20090192132 Pharmaceutical Composition |
| 07/30/2009 | US20090192131 Transdermal formulation containing androgen, macrocyclic ester or ketone enhancer and thickener; extended time high blood serum concentration; rapidly absorbed gel; treatment of male hypogonadism |
| 07/30/2009 | US20090192130 Method for Treating Uterine Fibroids |
| 07/30/2009 | US20090192129 Bicyclic pyrrole derivatives |
| 07/30/2009 | US20090192128 Genetic risk assessment in heart failure: impact of genetic variation of beta 1 adrenergic receptor gly389arg polymorphism |
| 07/30/2009 | US20090192127 Combination therapy comprising a diaryl urea compound and a p13, akt kinase or mtor inhibitors (rapamycins) for cancer treatment |
| 07/30/2009 | US20090192126 Oral Composition Comprising a Polyunsaturated Fatty Acid and Salicylic Acid for Obtaining an Antiinflammatory Effect in Skin |
| 07/30/2009 | US20090192125 Local anti-infective agent for treatment of nail fungal infections |
| 07/30/2009 | US20090192124 Use of ceramides for depigmenting the skin |
| 07/30/2009 | US20090192123 Optionally in combination with antithrombotic agents, ACE inhibitor, Angiotensin antagonist, Calcium antagonist, statins, or antidiabetic agents |
| 07/30/2009 | US20090192122 Inflammatory cytokine release inhibitor |
| 07/30/2009 | US20090192121 Novel bisamidate phosphonate prodrugs |
| 07/30/2009 | US20090192120 Inhibitors of nitric oxide synthase |
| 07/30/2009 | US20090192119 Inhibition of the Renin-Angiotensin System for the Treatment of Renal, Vascular and Cartilage Pathology |
| 07/30/2009 | US20090192118 Tak1-d mediated induction of cell death in human cancer cells by specific sequence short double-stranded rnas |
| 07/30/2009 | US20090192117 Compositions and methods for the suppression of target polynucleotides from lygus |
| 07/30/2009 | US20090192115 Use of compounds that interfere with the hedgehog signaling pathway for the manufacture of a medicament for preventing, inhibiting, and/or reversing ocular diseases related with ocular neovascularization |
| 07/30/2009 | US20090192113 Interfering RNA Duplex Having Blunt-Ends and 3`-Modifications |
| 07/30/2009 | US20090192112 Compositions and methods for treating cancer |
| 07/30/2009 | US20090192111 miR-124 Regulated Genes and Pathways as Targets for Therapeutic Intervention |
| 07/30/2009 | US20090192110 Rna antagonist compounds for the modulation of pik3ca expression |
| 07/30/2009 | US20090192109 Compositions for diagnosis and therapy of diseases associated with aberrant expression of Kremen and/or Wnt |
| 07/30/2009 | US20090192108 Gene overexpressed in cancer |
| 07/30/2009 | US20090192107 Breast Cancer Markers |
| 07/30/2009 | US20090192106 MODULATION OF eIF4E EXPRESSION |
| 07/30/2009 | US20090192105 RNA INTERFERENCE MEDIATED INHIBITION OF INTERCELLULAR ADHESION MOLECULE (ICAM) GENE EXPRESSION USING SHORT INTERFERING NUCELIC ACID (siNA) |
| 07/30/2009 | US20090192104 RNA INTERFERENCE MEDIATED INHIBITION OF HYPOXIA INDUCIBLE FACTOR 1 (HIF1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 07/30/2009 | US20090192103 Multitargeting Interfering RNAs Having Two Active Strands And Methods For Their Design And Use |
| 07/30/2009 | US20090192102 miR-21 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION |
| 07/30/2009 | US20090192101 Cancer-specific promoters |
| 07/30/2009 | US20090192100 Novel use of spiegelmers |
| 07/30/2009 | US20090192099 Prodrugs of heteroaryl compounds |
| 07/30/2009 | US20090192098 Method for treating hematopoietic neoplasms |
| 07/30/2009 | US20090192097 Synergistic Herbal Composition from Bacopa Species for Management of Neurodegenerative Disorders and a Process of Preparation Thereof |
| 07/30/2009 | US20090192096 2'-Substituted 1,1'-Biphenyl-2-Carboxamides, Processes For Their Preparation, Their Use As Medicaments, And Pharmaceutical Preparations Comprising Them |
| 07/30/2009 | US20090192095 Amino acid and peptide prodrugs of opioid analgesics with reduced gi side-effects |
| 07/30/2009 | US20090192094 Treatment of diseases using ice inhibitors |
| 07/30/2009 | US20090192093 Abuse-resistant amphetamine prodrugs |
| 07/30/2009 | US20090192085 FKBP-L And Uses Thereof |
| 07/30/2009 | US20090192084 Compositions and method of treating hypoxia-associated diseases |
| 07/30/2009 | US20090192077 North-2'deoxy -methanocarbathymidines as antiviral agents for treatment of kaposi's sarcoma-associated herpes virus |
| 07/30/2009 | US20090192074 Methods and pharmaceutical compositions for healing wounds |
| 07/30/2009 | US20090192071 Use of photodynamic therapy to enhance treatment with immuno-modulating agents |
| 07/30/2009 | US20090191650 Diagnosing alzheimer's disease via presence of variant brain membrane protein |
| 07/30/2009 | US20090191639 Non-Invasive Rapid Diagnostic Test For M.Tuberculosis Infection |
| 07/30/2009 | US20090191572 Imaging, diagnosis and treatment of disease |
| 07/30/2009 | US20090191568 Methods and compositions for predicting compliance with an antidepressant treatment regimen |
| 07/30/2009 | US20090191555 HCV NS3-NS4 Protease Resistance Mutants |
| 07/30/2009 | US20090191290 Dietary supplements containing extracts of cinnamon and methods of using same to enhance creatine transport |
| 07/30/2009 | US20090191288 Composition to Treat Herpes, Pseudomonas, Staph, Hepatitis and Other Infectious Diseases |
| 07/30/2009 | US20090191287 Mitigation of Inflammation-Related Injuries |
| 07/30/2009 | US20090191285 Moisturizing liquid liner for barrier layer |
| 07/30/2009 | US20090191283 Treatment of headaches, neck pain, joint pain and inflammatory-type pain |
| 07/30/2009 | US20090191282 Controlled release composition containing a strontium salt |
| 07/30/2009 | US20090191277 Protein nanoparticles |
| 07/30/2009 | US20090191275 Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
| 07/30/2009 | US20090191274 Pharmaceutical composition of amlodipine maleate having enhanced stability |
| 07/30/2009 | US20090191266 Pregelatinized Starch In A Controlled Release Formulation |
| 07/30/2009 | US20090191265 comprises 5-30% by wt of pharmaceutically acceptable excipients and 70-95% of 5-methyl-1-phenyl-2-(1H)-pyridone, where excipients comprise effective amount of binder to increase changes in blood concentration of pirfenidone upon oral administration, compared to capsule comprising no excipients; fibrosis |
| 07/30/2009 | US20090191264 Epothilone compositions |
| 07/30/2009 | US20090191263 Compositions and methods for sirna inhibition of hif-1 alpha |
| 07/30/2009 | US20090191262 Use of compounds of formula a-r-xo pharmaceutically acceptable salts thereof for producing a pharmaceutically preparations |
| 07/30/2009 | US20090191259 Efficient liposomal encapsulation |
| 07/30/2009 | US20090191253 Use of K-252a and Kinase Inhibitors for the Prevention or Treatment of HMGB1-Associated Pathologies |
| 07/30/2009 | US20090191245 Reduced-irritant dermatological compositions comprising at least one naphthoic acid compound and benzoyl peroxide and treatment of keratinization disorders therewith |
| 07/30/2009 | US20090191235 Conformationally stabilized hiv envelope immunogens and triggering hiv-1 envelope to reveal cryptic v3-loop epitopes |
| 07/30/2009 | US20090191229 Adjuvancy and immune potentiating properties of natural products of onchocerca volvulus |
| 07/30/2009 | US20090191215 Treatment with anti-VEGF Antibodies |
| 07/30/2009 | US20090191211 METHODS FOR DAMAGING CELLS USING EFFECTOR FUNCTIONS OF ANTI-EphA4 ANTIBODIES |
| 07/30/2009 | US20090191207 Compositions and methods for the prophylaxis or treatment of viral diseases |
| 07/30/2009 | US20090191206 Human Semen Enhancer of Viral Infection Peptides (SEVI) and Their Use |
| 07/30/2009 | US20090191203 Bcma Polypeptides And Uses Thereof |
| 07/30/2009 | US20090191196 Use |
| 07/30/2009 | US20090191194 Inhibition of protein kinase c alpha for the treatment of cardiovascular diseases |
| 07/30/2009 | US20090191189 Replikin peptides in rapid replication of glioma cells and in influenza epidemics |
| 07/30/2009 | US20090191188 Immunostimulatory nucleic acids |
| 07/30/2009 | US20090191185 Reducing Cancer Cell Invasion Using an Inhibitor of Toll Like Receptor Signaling |
| 07/30/2009 | US20090191183 Substituted indoles |
| 07/30/2009 | US20090191182 Compositions, Kits, and Methods for the Modulation of Immune Responses Using Galectin-1 |
| 07/30/2009 | US20090191177 Enantiomerically Pure (-) 2-[1-(7-methyl-2-(morpholin-4-yl)-4-oxo-4H-pyrido[1,2-A]pyrimidin-9-yl)ethylamino]benzoic Acid, Its Use In Medical Therapy, And A Pharmaceutical Composition Comprising It - 026 |
| 07/30/2009 | US20090191176 Chondroitin sulfate synthesis promoter |
| 07/30/2009 | US20090191170 Nucleic acid compositions and methods of introducing nucleic acids into cells |
| 07/30/2009 | US20090191166 Screening and therapy for lymphatic disorders involving the flt4 receptor tyrosine kinase (vegfr-3) |
| 07/30/2009 | US20090191162 Catecholamine Receptor Modulation |
| 07/30/2009 | US20090191156 Gm-csf cosmeceutical compositions and methods of use thereof |
| 07/30/2009 | US20090191153 Oximyl macrocyclic derivatives |
| 07/30/2009 | US20090191152 Intralymphatic chemotherapy drug carriers |
| 07/30/2009 | US20090191145 Adhesive systems containing polyisocyanate prepolymers and aspartate-ester curing agents, processes for preparing the same, medical uses therefor and dispensing systems for the same |
| 07/30/2009 | US20090191144 Use of lipid components against pollen allergies |
| 07/30/2009 | US20090191136 Use of active substance complexes of panthenol, glycerol, citrate and/or bisabolol against pollen allergies |
| 07/30/2009 | US20090191133 Modulation of stat 6 expression for the treatment of airway hyperresponsiveness |
| 07/30/2009 | US20090191132 Coded medication and methods of preparing same for identification and distinguishment |